Business ❯ Pharmaceutical Industry

Market Competition

Pricing Strategies Drug Pricing Novo Nordisk Eli Lilly Generic Drugs Drug Approval Drug Development Drug Sales Drug Launches Weight Loss Drugs

Amazon Pharmacy Rolls Out Lilly’s Foundayo With Same‑Day Delivery and Clinic Kiosks

Same-day delivery with clinic kiosks signals a shift to faster, broader access.

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

India Tightens Oversight of GLP-1 Drugs as Semaglutide Generics Proliferate

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

Novo’s CagriSema Falls Short of Lilly’s Tirzepatide in 84-Week Head‑to‑Head Trial

Bayer Sues J&J Over Erleada Marketing, Alleging False Superiority Claims Versus Nubeqa

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

Mexican Court Revives Denosumab Patent, Extends Amgen Exclusivity to 2027

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Trump Unveils TrumpRx.gov, a Government Coupon Site for Cheaper Prescriptions

FTC Reaches 10-Year Settlement With Express Scripts to Cut Insulin Costs and Reshape PBM Practices

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs